Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarrs Group Regulatory News (CARR)

  • There is currently no data for CARR

Board Changes

21 Feb 2023 07:00

RNS Number : 5025Q
Carr's Group PLC
21 February 2023
 

21 February 2023

Carr's Group plc

("Carr's", the "Company", or the "Group")

 Board Changes

 

Carr's (CARR.L), the Speciality Agriculture and Engineering group, announces that the following previously announced Board changes are applicable with immediate effect:

 

1. Tim Jones joins the Board as Non-Executive Chair;

2. Peter Page becomes Chief Executive Officer and relinquishes the role of Executive Chair;

3. David White joins the Board as Chief Financial Officer; and

4. Neil Austin stands down as Chief Financial Officer and from the Board.

 

The Group also announces that Martin Rowland will join the Board as a Non-Executive Director, effective 6 March 2023. 

 

Mr Rowland is appointed as a representative of Harwood Capital Management Limited ("Harwood") pursuant to a relationship agreement between the Company and Harwood. The primary purpose of the relationship agreement is to ensure that the Company is capable of carrying on its business independently at all times. In accordance with the terms of the relationship agreement, Mr Rowland shall be entitled to remain on the Board of Directors of the Company provided that Harwood retains an aggregate interest of at least 5% of the Company's issued ordinary share capital. As at the date of this announcement, Harwood held an aggregate interest of 6.04% of the Company's issued ordinary share capital.

 

Mr Rowland is currently Non-Executive Chairman of AIM-listed Smoove plc, a provider of technology solutions for the housing sector. He has spent the last 14 years in a variety of investment roles, working for institutional private equity houses and investing alongside family offices. Prior to this Martin held operational and strategic roles in mid-sized and large corporates. He has been a director of companies in an executive and non-executive capacity, helping businesses to scale organically and through acquisition. 

 

In accordance with Listing Rule 9.6.13, on 12 November 2008, DLG Equity Holdings Limited, of which Martin Rowland had previously been a Director, together with its subsidiaries DLG Finance Limited, DLG Bidco Limited, DLG Holdings Limited, DLG Acquisitions Limited, Data Locator Group Limited, Epic Care Limited and Call Connector Limited, entered into administration. The companies subsequently entered into creditors voluntary liquidation and were liquidated on 21 May 2012 with a shortfall to creditors of £35.3 million.

 

There are no other matters in respect of Mr Rowland's appointment requiring disclosure under UK Listing Rules 9.6.13(1) to 9.6.13(6) inclusive.

 

Enquiries:

 

Carr's Group plc

+44 (0) 1228 554 600

Peter Page

Matthew Ratcliffe

 

FTI Consulting

+44 (0) 20 3727 1340

Richard Mountain/Ariadna Peretz

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAEAEASNDEAA
Date   Source Headline
13th Jan 20157:00 amRNSInterim Management Statement
12th Jan 20154:53 pmRNSTotal Voting Rights - Replacement
12th Jan 201511:30 amRNSTotal Voting Rights
8th Jan 20157:00 amRNSTotal Voting Rights
16th Dec 20144:10 pmRNSBlock Listing Application
16th Dec 20144:03 pmRNSAdditional Listing
16th Dec 20144:00 pmRNSBlock Listing Six Monthly Return
5th Dec 201410:31 amRNSDirector/PDMR Shareholding
28th Nov 20148:28 amRNSTotal Voting Rights
10th Nov 201412:44 pmRNSFinal Results - Replacement
10th Nov 20147:00 amRNSFinal Results
31st Oct 20143:23 pmRNSTotal Voting Rights
29th Sep 201411:12 amRNSTotal Voting Rights
11th Sep 201412:46 pmRNSDirector/PDMR Shareholding
9th Sep 20141:51 pmRNSHolding(s) in Company
5th Sep 20144:51 pmRNSDirector/PDMR Shareholding
8th Aug 20145:11 pmRNSHolding(s) in Company
8th Aug 201412:53 pmRNSTotal Voting Rights
25th Jul 20147:00 amRNSAnalyst & Investor Day
21st Jul 20147:00 amRNSSecond Interim Dividend
15th Jul 20147:00 amRNSInterim Management Statement
14th Apr 20147:00 amRNSInterim Results
9th Apr 20147:00 amRNSAcquisition
2nd Apr 20144:35 pmRNSPrice Monitoring Extension
10th Feb 20143:10 pmRNSDirector/PDMR Shareholding
21st Jan 20144:22 pmRNSDirector/PDMR Shareholding
15th Jan 20142:50 pmRNSResult of AGM
14th Jan 20147:00 amRNSInterim Management Statement
6th Jan 20144:45 pmRNSDirector/PDMR Shareholding and Total Voting Rights
11th Nov 20137:00 amRNSFull Year Results
17th Sep 20137:00 amRNSUpdate on Kirkcaldy mill and notice of results
30th Aug 201311:25 amRNSTotal Voting Rights
20th Aug 20137:00 amRNSFurther US expansion
1st Aug 20137:00 amRNSDirectorate Change
15th Jul 20137:00 amRNSInterim Management Statement
28th Jun 20137:00 amRNSTotal Voting Rights
13th Jun 201311:33 amRNSDirector/PDMR Shareholding
11th Jun 20137:00 amRNSAcquisition
10th Jun 201310:39 amRNSPurchase of own shares
1st May 20137:00 amRNSDirectorate Change
16th Apr 20137:00 amRNSInterim Results
11th Apr 20134:40 pmRNSSecond Price Monitoring Extn
11th Apr 20134:35 pmRNSPrice Monitoring Extension
28th Mar 201311:41 amRNSTotal Voting Rights
11th Mar 20134:05 pmRNSDirectorate Change
28th Feb 20137:00 amRNSTotal Voting Rights
19th Feb 201310:23 amRNSDirector/PDMR Shareholding
8th Jan 20137:00 amRNSInterim Management Statement
12th Nov 20127:00 amRNSFinal Results
31st Oct 20124:48 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.